3 June 2021
ArborGen Announces Director Nominations Closing Date
ArborGen Holdings Limited (NZX: ARB) advises that the closing date for director nominations is 21 June 2021.
26 May 2021
Results Announcement - For the 12 months ended 31 March 2021
ArborGen Holdings Reports US$3.2m Net Profit, Projects Increasing Advanced Genetics Sales
9 May 2021
ArborGen Holdings Advises Uplift in FY21 Guidance
Global advanced genetics seedling company, ArborGen Holdings Limited (NZX: ARB) has advised of an uplift in the Company’s earnings guidance.
1 March 2021
ArborGen receives second PPP loan
ArborGen Holdings announced today that its wholly owned subsidiary in the US, ArborGen Inc., has received approval and funding from the Small Business Administration (SBA) under the CARES Act Paycheck Protection Program (PPP) for a second loan in the amount of US$1.95 million.
12 January 2021
ArborGen Holdings’ Market Update
To keep the market updated in the current environment, ArborGen Holdings announced today that confirmed sales orders in its largest market, the United States, currently represent around 92% of forecast US seedling revenues for the year.
29 November 2020
ArborGen Holdings Issues New Shares Under the Executive Fixed Trading Plan
In accordance with the provisions of an Executive Fixed Trading Plan (Plan), ArborGen Holdings today issued 216,347 new shares to Andrew Baum (CEO).
16 November 2020
ArborGen Renegotiates and Extends Synovus Agreement
ArborGen Holdings (ArborGen) announced today the renegotiation and extension of its revolving credit facility agreement with Synovus Financial Corporation (Synovus) relating to a $17 million letter of credit (LOC) facility in the US.
10 November 2020
ArborGen and Vallourec Sign Eucalyptus Commercialisation Agreement
Today, ArborGen, a world leader in the development and commercialisation of technologies that improve the productivity of trees, announced that it has entered into an agreement with Vallourec S.A. that gives ArborGen exclusive rights to develop and commercialise Vallourec’s genetically improved eucalyptus clones in Brazil.
20 September 2020
ArborGen Holdings Vests Restricted Shares Under the 2018 and 2019 Non-Executive Director’s Share Plans
In accordance with a provisions of both the 2018 and 2019 Non-Executive Director’s Share Plans, approved by shareholders on 17 September 2018 and 17 September 2019 respectively, the following shares have vested - 185,117 shares vested to each of the three Directors (Tom Avery, Ozey Horton and Paul Smart) under the 2018 share plan and 273,666 vested to George Adams under the 2019 share plan.